Monsanto
Monsanto is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Monsanto.
Monsanto is a company.
Key people at Monsanto.
Key people at Monsanto.
Monsanto was an American agrochemical and agricultural biotechnology corporation founded in 1901, initially focused on chemical products like the artificial sweetener saccharin, and later becoming a leader in genetically modified (GM) seeds, herbicides such as Roundup (glyphosate-based), and crop biotechnology.[1][2][3] It served farmers worldwide by developing seeds resistant to pests, weeds, drought, and herbicides, alongside complementary chemicals, aiming to boost crop yields amid growing global food demands.[2][3][4] The company solved key agricultural challenges like weed and pest control but faced intense scrutiny over health and environmental impacts of its products; it was acquired by Bayer in 2018 for $63 billion, effectively ending its independent operations as a subsidiary integrated into Bayer's crop science division.[1][7]
Monsanto was founded in 1901 in St. Louis, Missouri, by John F. Queeny, a former purchasing agent for a drug wholesaler, who invested $1,500 of his own money (borrowing another $3,500) to produce saccharin, then solely imported from Germany; he named the company after his wife Olga Monsanto Queeny.[1][2][3][4] Early growth accelerated during World War I when U.S. chemical imports halted, allowing Monsanto to supply saccharin (a major Coca-Cola customer), caffeine, vanillin, aspirin, and industrial chemicals like styrene for synthetic rubber, reaching $1 million in sales by 1915.[1][2][5] Queeny handed control to his son Edgar Monsanto Queeny in 1928, who expanded it into an industrial giant producing sulfuric acid, PCBs, and more; the company incorporated as Monsanto Chemical Company in 1933 and renamed Monsanto Company in 1964 amid diversification into agrochemicals.[1][3][4]
Pivotal shifts occurred in the 1980s–1990s: Monsanto pioneered plant genetic modification in 1983 (one of four groups to do so), conducted the first U.S. field trials of GM crops in 1987, and acquired biotech firms like Calgene and DEKALB Genetics, launching Roundup Ready seeds tolerant to glyphosate in 1996.[2][3][4] Earlier ventures included Agent Orange production during the Vietnam War and the 1985 purchase of NutraSweet maker G.D. Searle (sold in 2000).[1][4]
Monsanto rode the biotech revolution in agriculture, capitalizing on 1980s gene-editing breakthroughs amid rising global food needs from population growth and arable land limits.[3][5] Timing was ideal post-Green Revolution, as traditional breeding plateaued; its GM seeds addressed climate-resilient farming, influencing 90%+ of U.S. soybeans/corn acreage by the 2010s.[2] Market forces like deregulation (e.g., U.S. GM approvals) and herbicide resistance in weeds favored its Roundup-seed bundle, reshaping industrial agriculture toward precision, input-heavy models.[2][5] It drove consolidation in agrotech, inspiring rivals while sparking debates on seed patents, biodiversity, and chemical dependency, ultimately amplifying Bayer's dominance in a $130B+ crop science market.[1][7]
Post-2018 Bayer acquisition, Monsanto's legacy endures as Bayer Crop Science, facing ongoing glyphosate lawsuits (e.g., cancer links) but advancing CRISPR-edited crops and digital farming tools like AI-driven analytics for precision agriculture.[1][2] Trends like climate adaptation, sustainable ag (e.g., reduced-till GMOs), and gene-drive tech will shape its path, potentially expanding into non-GM biologics amid regulatory pressures in Europe/Asia. Influence may evolve toward integrated platforms blending biotech, data, and robotics, solidifying its foundational role in feeding 10B people by 2050—though reputational scars from past controversies could temper growth unless offset by verifiable sustainability gains. This arc from saccharin startup to agribiotech titan underscores resilient adaptation in contested terrains.
